ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,521 Cr | ₹1,411 Cr | ₹1,260 Cr | ₹1,149 Cr | ₹971 Cr |
What is the latest Total Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,521 Cr |
Mar2023 | ₹1,411 Cr |
Mar2022 | ₹1,260 Cr |
Mar2021 | ₹1,149 Cr |
Mar2020 | ₹971 Cr |
How is Total Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,521 Cr | 7.85 | |
Mar2023 | ₹1,411 Cr | 11.93 | |
Mar2022 | ₹1,260 Cr | 9.65 | |
Mar2021 | ₹1,149 Cr | 18.34 | |
Mar2020 | ₹971 Cr | - |
Compare Total Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,689.9 Cr | -2.9% | -5.9% | -11.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,461.0 Cr | 1.4% | -4.1% | 32.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,983.0 Cr | -4.2% | -5.1% | 59.6% | Stock Analytics | |
CIPLA | ₹112,735.0 Cr | -2.2% | -7.3% | 0.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,913.9 Cr | -7.1% | -13.8% | 8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,815.0 Cr | -6.4% | -5.2% | 31.2% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | -2.9% |
-5.9% |
-11.8% |
SENSEX | -2.2% |
-4% |
5.5% |
You may also like the below Video Courses